Examining Opportunities to Increase Savings From Medicare Price Negotiations.

ABSTRACT:

Importance

Allowing the US Centers for Medicare & Medicaid Services to negotiate prescription drug prices for Medicare may improve drug affordability.

Objective

To estimate savings from Medicare price negotiation under the Inflation Reduction Act (IRA) and examine opportunities to increase savings.

Design, setting, and participants

This cross-sectional, population-based study used data from 2020 Medicare prescription drug claims. The study was conducted and data were analyzed in 2022.

Exposures

Eligibility for Medicare price negotiation under the IRA and alternative criteria.

Main outcomes and measures

Minimum savings under the IRA's eligibility criteria were estimated and compared with savings within alternative scenarios, including (1) selecting drugs

SUBMITTER: Reitsma MB 

PROVIDER: S-EPMC10111230 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature